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1. Pathology and molecular biology update on 
neuroendocrine tumours: what clinicians should  
know in 2014
H Sasano
Department of Pathology, Tohoku University School of Medicine, Sendai, 
Japan 
The incidence and prevalence of neuroendocrine tumours (NETs) 
or neuroendocrine  neoplasm (NEN) has been increasing recently, 
especially in the gastrointestinal tract and pancreas. Recently, these 
tumours were classified into G1, G2 and G3/neuroendocrine  (NEC) 
based upon mitotic counts or Ki-67 labelling index [World Health 
Organization (WHO), 2010]. This is because the clinical outcome of 
patients with NEN is largely determined by this newly developed 
histological and of Malignant Tumours (TNM). However, controversies 
exist as to the surrogate markers of novel target specific therapies and 
further subclassification of G3/NEC because of different responses 
by these patients to platinum-based chemotherapy. In particular, 
the former relates to the markers of somatostatin analogues and/
or  inhibitors, while the latter relates to optimal cut-off points of Ki-67 
labelling index or the inclusion of histological features of the tumour 
cells, such as small cell carcinoma in NEC or G3 cases. In addition, it is 
also important for clinicians to recognise that there are two different 
TNM classifications, WHO versus ENET, which could yield different 
stages in the same patients with pancreatic NET. Molecular studies 
of NETs/NEN have revealed several putative prognostic markers or 
putative therapeutic targets including Id, ATM, SRC, , heat shock 
protein 90 and. Endocrinologists should be aware that currently, the 
clinical algorhythm of NEN patients, especially treatment decisions, is 
not necessarily based on hormonal features, but rather pathological 
and molecular features of the disorder.
2. Differential optimal obesity indices identify metabolic 
syndrome in black men and women in Cape Town:  
the CRIBSA Study
N Peer,1 C Lombard,2 K Steyn,3 N Levitt3
1Non-Communicable Diseases Research Unit, Medical Research Council
2Biostatistics Unit, Medical Research Council
3Department of Medicine, University of Cape Town
Objective: To determine the optimal obesity indices, specifically waist 
circumference (WC), that identify ≥ 2 other metabolic syndrome (MS) 
components defined by the 2009 harmonised criteria in the 25- to 
74-year-old black population of Cape Town. 
Method: In 2008/2009, a representative cross-sectional sample, 
stratified for age and sex, was randomly selected. Data were 
collected by administered questionnaires, clinical measurements 
and biochemical analyses, including fasting and 120-minute 
blood samples. Optimal obesity cut-off points were estimated by 
the Youden index. Logistic regression analyses, adjusted for age, 
determined whether or not obesity cut-off points that identified 
≥ 2 MS components occurred at true inflection points.
Results: There were 1 099 participants; of whom 392 were men and 
707 women. The optimal cut-off points and 95% confidence intervals 
(CIs) were men, WC 83.9 cm (81.6-86.2), waist-to-hip ratio (WHR) 0.89 
(0.87-0.90), waist-to-height ratio (WHtR) 0.50 (0.48-0.52), and body 
mass index (BMI) 24.1 kg/m2 (22.0-26.1); and women, WC 94 cm (91.9-
96), WHR 0.85 (0.83-0.87), WHtR 0.59 (0.57-0.60), and BMI 32.1 kg/m2 
(29.7-34.6). The presence of ≥ 2 MS components was significantly 
associated with raised WC in men: WC 84-93.9 cm [odds ratio (OR) 
3.19, 95% CI: 1.73-5.85 and WC ≥ 94 cm, OR: 8.50, 95% CI: 4.44-16.25] 
compared to WC < 84 cm; and in women, WC 80-93.9 cm, OR: 
2.93, 95% CI: 1.32-6.54 and WC ≥ 94 cm, OR: 5.33, 95% CI: 2.40-11.85, 
compared to WC < 80 cm. The presence of ≥2 MS components in 
the logistic model with BMI for women was not associated with 
overweight (p-value 0.063), while obesity was significantly related 
(OR: 3.60, 95% CI: 1.82-7.10).
Conclusion: WC and other obesity cut-off points currently 
recommended in the black population should be re-evaluated and 
adjusted accordingly.
3. Insulin secretion in relation to insulin sensitivity  
differs in black South African men and women with 
increasing age
JH Goedecke,1 N Peer,1 K Steyn,3 H Victor,2 NS Levitt3
1Non-communicable Disease Research Unit, South African Medical 
Research Council
2Department of Human Biology, University of Cape Town
3Department of Medicine, University of Cape Town
We have previously shown that premenopausal black South African 
women are more insulin resistant than their white counterparts and 
hypersecrete insulin to maintain normoglycaemia. This study aimed 
to examine the effect of age and sex on insulin secretion relative to 
insulin sensitivity in black South African men and women. The subjects 
were men (n = 237) and women (n = 346), aged 25-74 years, without 
known diabetes, randomly selected from a peri-urban setting in Cape 
Town. They underwent an oral glucose tolerance test (OGTT), from 
which insulin sensitivity [insulin sensitivity index (ISI0, 120)] and secretion 
[insulinogenic index (IGI)] were estimated, and the disposition index 
(DI) calculated, i.e. DI = ISI x IGI. Despite marked differences in BMI 
between the men and women [median (interquartile range): 23.5 
(20.1-25.8) vs. 32.3 (26.3-36.9) kg/m2, p-value < 0.001], the prevalence 
of impaired glucose tolerance (IGT) (15.2 vs. 13.3%) and type 2 
diabetes (3 vs. 4.6%) did not differ (p-value 0.508), and increased 
similarly with age in both sexes (p-value < 0.001). However, ISI0, 120 
was higher [7.4 (4.3-9.1) vs. 5.2 (3.6-6.1) mg.l2/mU.minute, p-value 
0.009), but both IGI 25.4 (6.8-30.8) vs. 58.3 (12.8-62.7) mU/mmol, 
p-value < 0.001) and DI [100.6 (37.9-232) vs. 140 (51.1-303.3) mg.l2/
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mmol.minute, p-value 0.01)] were lower in men than in women, after 
adjusting for age and BMI. ISI decreased in men with increasing age, 
but not in women (p-value 0.006), whereas the rate of decrease in 
IGI with increasing age was greater in women than in men (p-value 
0.025). Consequently, the decrease in DI with increasing age did 
not differ by sex (p-value 0.090), but remained significantly higher 
in women than men across all age categories (p-value 0.015). In 
conclusion, insulin secretion in relation to insulin sensitivity decreases 
with increasing age, but remains higher in women than in men across 
all age categories, independent of BMI. 
4. Adipose tissue extracellular matrix gene expression in 
black and white South African women has a different 
association with insulin sensitivity in obesity
L Kotze, D Keswell, M Tootla, JH Goedecke
University of Cape Town
Objective: We have previously shown that black South African 
women have higher subcutaneous adipose tissue (SAT) inflammatory 
gene expression and reduced adipogenic capacity in the gluteal 
SAT depot, which correlates with reduced insulin sensitivity (SI) in 
black, but not white, women. We hypothesise that this phenotype 
in black women may be associated with increased expression of 
extracellular matrix (ECM) components in SAT, compared to that in 
white women. Therefore, the aim of the study was to compare the 
gluteal SAT expression of ECM components between normal-weight 
and obese black and white women, and to examine the ethnic-
specific associations with SI.
Method: Body composition was determined using dual-energy 
X-ray absorptiometry (DXA) and computed tomography (CI). SI 
[frequently sampled intravenous glucose tolerance test (GTT)] and 
gluteal SAT gene expression levels of ECM-related genes [collagen 
5a1 (COL5a1), collagen 6a1 (COL6a1), fibroblast growth factor 1 
(FGF1), hypoxia-inducible factor 1 (HIF1), lysyl oxidase 1 (LOX1) and 
adipogenic gene, i.e. peroxisome proliferator-activated receptor 
γ (PPARγ), as well as vascular endothelial growth factor α (VEGFα)] 
were measured in normal-weight (BMI 18-25 kg/m2) and obese (BMI 
> 30 kg/m2) black (n = 26) and white (n = 22) South African women.
Results: The gluteal SAT expression of HIF1, LOX1 and FGF1 were higher 
in obese than in normal-weight women (p-value < 0.01). VEGFα 
and PPARγ were downregulated in obese black, but not white, 
women (p-value 0.016 and p-value  0.015, respectively). COL5a1 
and COL6a1 expression was higher in obese black women (p-value 
< 0.000, p-value 0.029) than in obese white women. When adjusting 
for fat mass, HIF1 and COL6a1 expression correlated negatively with 
SI in black (r = -0.55, p-value 0.005; r = -0.47, p-value 0.019), but not in 
white women.
Conclusion: Black South African women have higher ECM gene 
expression than white women, and the relationship between ECM 
gene expression and insulin resistance is stronger in black than in white 
women. Increased ECM deposition may be another contributing 
factor to increased insulin resistance, as observed in black women. 
5. Bariatric surgery: effects on glucose homeostasis
J Dixon
Clinical Obesity Research, Baker IDI Heart & Diabetes Institute
Baker IDI Weight Assessment and Management Clinic, Monash University, 
Melbourne, Australia
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6. Do we need new criteria for gestational diabetes?
DR Coustan
Professor of Obstetrics and Gynecology, Warren Alpert Medical School 
of Brown University, Providence, USA
Various approaches to diagnosing gestational diabetes are in use 
throughout the world, but none are based on their prediction of 
adverse pregnancy outcomes. The Hyperglycemia and Adverse 
Pregnancy Outcome (HAPO) collected outcome data on over 
23 000 pregnancies in nine countries after a blinded 75-g, two-hour 
OGTT at 24-28 weeks gestation [HAPO Study Cooperative Research 
Group, et al. N Engl J Med. 2008; 358(19):1991-2002]. All four primary 
outcomes (large for gestational age, primary Caesarean section, 
neonatal hypoglycemia and high cord C-peptide), and most 
2-degree outcomes, e.g. pre-eclampsia, preterm birth, shoulder 
dystocia and birth injury, were significantly and directly related to each 
of the three plasma glucose measurements. With no inflection point 
in the curves relating to maternal glucose and pregnancy outcomes, 
assignment of thresholds for gestational diabetes was relatively 
arbitrary. The International Association of Diabetes and Pregnancy 
Study Group recommendations [Diab Care. 2010;33(3):676-682] 
include the use of a 75- g, two-hour OGTT with one or more elevations 
diagnosing gestational diabetes. Thresholds are fasting plasma 
glucose ≥ 92 mg/dl (5.1 mmol/l), at one hour ≥ 180 mg/dl (10 mmol/l) 
and two hours ≥153 mg/dl (10.5 mmol/l). These recommendations 
are being considered for adoption throughout the world because 
they are pregnancy outcome-based, the 75-g glucose load will bring 
consistency to GTTs, universal adaption will lead to consistency of 
diagnostic criteria worldwide, studies of treatment at similarly mild 
levels of glycaemia have demonstrated improvement in outcomes, 
and use of a single abnormal value will obviate the confusion arising 
when one elevated value is encountered. They have been adopted 
by the WHO.
The primary argument against using the new recommendations is the 
fact that the prevalence of gestational diabetes will rise to 16-18%. 
Increased cost in dollars and healthcare provider time will result. The 
health concerns of the increasing epidemic of obesity, prediabetes 
and diabetes throughout the world should be balanced against 
these cost concerns. For example, in the USA in 2010, 31% of women 
of childbearing age had prediabetes (26.4%) or diabetes (4.5%).  
7. High prevalence of cardiometabolic abnormalities in 
urban dwelling South Africans with diabetes: the CRISBA 
study
N Peer,1 K Steyn,2 C Lombard,3 N Levitt2
1Non-Communicable Diseases Research Unit, Medical Research Council
2 Department of Medicine, University of Cape Town
3Biostatistics Unit, Medical Research Council
Objective: This study aimed to determine the prevalence and 
associations of other cardiometabolic risk factors with diabetes in 
25- to 74-year-old urban Africans in Cape Town.
Method: In 2008/2009, a representative cross-sectional 
sample, stratified for age and gender, was randomly selected. 
Cardiometabolic risk factors were determined by administered 
questionnaires, clinical measurements and biochemical analyses, 
including fasting and 120-minute blood samples. Logistic regression 
analysis assessed the independent associations of cardiometabolic 
risk factors with diabetes. 
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Results: Of the 1 099 study participants, 160 (45 men and 115 
women) were identified with diabetes. Participants with diabetes 
had a significantly higher prevalence of blood pressure (BP) ≥ 130/ 
80 mmHg or hypertension treatment (82.6% vs. 53.5%), total cholesterol 
> 5 mmol/l (37.3% vs. 22.3%), triglycerides > 1.5 mmol/l (32% vs. 14%) 
and low-density lipoprotein cholesterol (LDL cholesterol) > 3 mmol/l 
(63.3% vs. 39.8%) than those without it. Obesity indices were higher 
in those with diabetes than in those without it: BMI ≥ 25 kg/m2: men 
54.9% vs. 25.9%, women 98.5% vs. 80.3%; WC: men ≥ 94 cm: 51.9% vs. 
16.4%, women ≥ 80 cm: 99.4% vs. 83.8%. These rates were similar in 
known and unknown diabetes. In the multiple logistic model, after 
adjusting for age and gender, diabetes was significantly associated 
with raised BP (OR 2.19, 95% CI: 1.18-4.06, p-value 0.013), raised LDL 
cholesterol (OR: 1.58, 95% CI: 1.04-2.40, p-value 0.030) and raised WC 
(OR: 3.61, 95% CI: 2.01-6.48, p-value > 0.001).
Conclusion: The high prevalence of cardiometabolic abnormalities 
with diabetes reinforces the importance of searching for and 
treating these risk factors in urban Africans with diabetes to reduce 
complications.
8. Screening for diabetes and hypertension in Zandspruit, 
Johannesburg
EM Webb, P Rheeder, S Lawson, DG van Zyl, T Karimba
University of Pretoria; Project HOPE
Objective: Sixteen screening days were carried out in the Zandspruit 
and Cosmo City area of Johannesburg as part of a larger study that 
focused on the improvement of community awareness of diabetes 
and hypertension.
Method: Final-year nursing students, supervised by a registered nurse 
from the Empilweni Nursing College, with the support of community 
volunteers, screened patients who provided consent to have their BP, 
BMI, WC and random glucose measured. Patients received a patient 
information leaflet in which there was space for their results to be 
captured. After the last test, patients sat with a nurse to discuss their 
results and possible next steps. Results were captured anonymously, 
except for those deemed to be in need of immediate referral. 
Patients’ data were classified according to the 2012 Society for 
Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) 
guidelines.
Results: We screened 5 525 people. 55.3% were female and the mean 
age was 35 years. Only 46% of those screened had normal random 
glucose (defined as < 5.6 mmol/l) and only 37.9% had a systolic blood 
pressure (SBP) below 120 mmHg. The mean SBP and diastolic blood 
pressure (DBP) for the screened population was 128 mmHg and 82 
mmHg, respectively. There was a significant difference in the BMI 
between men and women. Also, 80% of men had a WC below 94 
cm, whereas only 21.5% of females had a WC below 80 cm.
Conclusion: In a relatively young population of Zandspruit and Cosmo 
City in Johannesburg, a large proportion of persons with high SBP and 
random glucose values was found. The data guided an intervention 
with the establishment of a privately funded clinic to assist with both 
diabetes and hypertension care in the Zandspruit and Cosmo City 
settlements.
9. The prevalence and incidence of diabetes mellitus and 
other disorders of glycaemia in South African black 
patients on antiretroviral therapy
N Magula, AA Motala, UG Lalloo
Nelson R Mandela School of Medicine
This study determined the prevalence, incidence and predictors of 
dysglycaemia in adult subjects of second-generation Zulu descent 
on antiretroviral therapy (ART).
Human immunodeficiency virus (HIV)-infected ART-naive patients 
eligible for ART (group 1, n = 150); and age, gender, ethnically 
matched HIV-infected patients who were not eligible for ART (group 
2, n = 88); as well as HIV-negative subjects (group 3, n = 88) were 
included. WHO criteria for diabetes mellitus, IGT and impaired fasting 
glucose (IFG), using the OGTT and haemoglobin A1c (HbA1c) were 
used to compare prevalence in the groups at baseline. Group 1 was 
followed for 24 months on ART.
At baseline, the prevalence of diabetes mellitus was 0% in groups 
1 and 2, and 4.94% in group 3, p-value 0.005; IGT prevalence was 
2.96%, 2.4% and 3.7%, and IFG 0.7%, 1.2% and 0%, in groups 1, 2 and 
3, respectively. Of 150 persons in group 1, 13 developed diabetes 
mellitus during 219.2 person-years follow-up (PYFU), [incidence: 5.9 
cases per 100 PYFU (95% CI: 3.2-10.1)]; 11 developed IGT during 217.9 
PYFU [incidence: 5 cases per 100 PYFU (95% CI: 2.5-9)]; and eight 
developed IFG during 216.3 PYFU [incidence: 3.7 cases per 100 PYFU 
(95% CI: 1.6- 7.3)]. Significant predictive risk factors in multivariate 
analysis for future dysglycaemia included SBP for diabetes melliuts 
[OR 1.05 (95% CI: 1.01-1.09)], p-value 0.03); SBP [(OR 1.04 (95% CI: 1.0-
1.07), p-value 0.01)] and CD4 cell count [OR 0.98 (95% CI: 0.97-0.99), 
p-value 0.02)] for IGT and visceral fat by CT scan for IFG [OR 1.02, 95% 
CI: 1.004-1.03), p-value 0.01].
There is a high incidence of dysglycaemia in these subjects on ART 
and this underscores the importance of monitoring.
10. Testosterone deficiency, replacement and safety in 
cardiovascular disease
TH Jones
Centre for Diabetes and Endocrinology, Barnsley Hospital, Barnsley, and 
Department of Human Metabolism, University of Sheffield, Sheffield, UK
Low testosterone is associated with an increased risk of all-cause and 
cardiovascular mortality in the majority of prospective community-
based and cardiovascular disease (CVD) population studies. 
Endogenous testosterone levels in the mid- to upper-normal range 
are associated with the lowest cardiovascular events and mortality. 
Testosterone deficiency is associated with an adverse effect on 
the cardiovascular risk profile, which includes central adiposity, 
dyslipaemia, hypertension, glucose intolerance, endothelial 
dysfunction and raised inflammatory cytokines. The question arises as 
to whether or not low testosterone is merely a biomarker for chronic 
inflammation or contributes to the progression of atherosclerosis. 
Animal studies on low testosterone states promote early changes 
of atherogenesis which are ameliorated by testosterone. Carotid 
intimal-media thickness is greater with low testosterone and worsens 
over time. Hypogonadism and/or erectile dysfunction may be the first 
symptoms of CVD. 
The second question is whether or not testosterone replacement 
therapy would have a beneficial effect on men with CVD, apart 
from those that relate specifically hypogonadism. When testosterone 
has been replaced and carefully titrated to the mid range, no 
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increased risk in cardiovascular events occurred, and there were 
benefits with regard to cardiovascular risk factors, cardiac ischaemia 
and functional exercise capacity in heart failure. No initial diagnosis 
of hypogonadism or poor comparator groups then cardiovascular 
events may be expected in studies where either subjects may be 
over- or undertreated. Careful diagnosis, titrated replacement and 
monitoring are important.
11.  Tissue non-specific alkaline phosphatase functions to 
generate inorganic phosphate which mediates lipid 
accumulation in 3T3-L1 preadipocytes
E Cave, N Crowther
University of the Witwatersrand
Background: Within osteoblasts, tissue-nonspecific alkaline 
phosphatase (TNSALP) hydrolyses inorganic pyrophosphate (PPi), 
an inhibitor of bone mineralisation, into inorganic phosphate (Pi), 
an activator of differentiation and mineralisation. Intracellular lipid 
accumulation in the preadipocyte cell line, 3T3-L1, is characteristic of 
cell maturation (adipogenesis) and is blocked by inhibition of TNSALP. 
We hypothesise that TNSALP mediates intracellular lipid accumulation 
in preadipocytes by increasing the intracellular levels of Pi.      
Method and results: While undergoing adipogenesis, treatment of 
3T3-L1 cells with an inhibitor (probonecid) of the progressive ankylosis 
protein (ANK) transported PPi out of cells, leading to significant 
increases in intracellular PPi concentration (p-value < 0.05), (148%, 
11.25), TNSALP activity (283%, 57.8), intracellular Pi level (148%,  34.44) 
and increased intracellular lipid accumulation (150.44%, 24) when 
compared to untreated cells (100%). Inhibition of TNSALP activity, with 
levamisole, resulted in a cessation of intracellular lipid accumulation, 
an effect that was reversed by the addition of Pi. 
Conclusion: Therefore, the function of TNSALP in intracellular lipid 
accumulation is to generate intracellular Pi, which may act as a 
regulator of gene expression in preadipocytes. Pi is known to increase 
expression of the transcription factor, Nrf2, within osteoblasts, a 
molecule that is also essential for adipogenesis within preadipocytes. 
This work has been funded by the National Health Laboratory 
Service, the National Research Foundation of South Africa, and the 
Faculty of Health Sciences Research Committee, University of the 
Witwatersrand.
12. Seroprevalence of antithyroid peroxidase and 
antiparietal cell antibody positivity in patients with  
type 1 diabetes in KwaZulu-Natal
IM Paruk,1 Y Ganie,2 S Maharaj,1 FJ Pirie,1 VG Naidoo,3 F Nkwenyama,4 HL 
Dinnematin,5 PK Ramdial,6 AA Motala1
Departments of 1Diabetes and Endocrinology, 2Paediatrics, 
3Gastroenterology and Hepatology, 4Public Health
Medicine; Nelson R Mandela School of Medicine, University of 
KwaZulu-Natal
5Departments of Haematology, 6Anatomical Pathology; Inkosi Albert 
Luthuli Hospital, Durban, KwaZulu-Natal
Objective: To assess the prevalence of antithyroid peroxidase 
antibodies and antiparietal cell antibodies in patients with type 1 
diabetes attending the outpatient tertiary diabetes clinic at Inkosi 
Albert Luthuli Hospital in Durban, KwaZulu-Natal.                                                                  
Method: This was a cross-sectional observational study on subjects 
with type 1 diabetes attending the adult diabetes clinic at Inkosi 
Albert Luthuli Hospital in Durban. Information collected from patients 
included history, a clinical examination and laboratory tests. Blood 
tests included those for the anti-glumatic acid decarboxylase (GAD) 
antibody, antithyroid peroxidase (anti-TPO) antibody, antiparietal 
antibody, coeliac antibodies, B12, folate, ferritin, thyroid-stimulating 
hormone (TSH), free thyroxine, creatinine, serum lipids and HbA1c. 
Results: A total of 202 (90 male to 112 female) patients were recruited. 
The ethnic composition was African (56.4%, n = 114), Indian (31.7%, 
n = 64), white (4.5%, n = 9 and coloured (7.4%, n = 15). The mean 
age of the study population and mean duration of diabetes was 
26.4 + 11.4 and 10.7 + 9.1 years, respectively. The mean BMI was 
21.6 + 6.3 kg/m2. Twenty-three patients (11.4%) were known to have 
primary hypothyroidism on chronic thyroxine therapy, either due to 
Hashimoto’s disease (n = 21) or Graves’ disease post-radioiodine 
therapy (n = 2). The GAD antibody was found in 63.37% (n = 128) of 
the total study group. Anti-TPO and antiparietal antibody prevalence 
was 18.91% (n = 39) and 8.91% (n = 17), respectively.  
Conclusion: Patients with type 1 diabetes frequently have co-existent 
autoimmune thyroid disease and evidence of gastric autoimmunity. 
Screening for these conditions should be undertaken in patients with 
type 1 diabetes, although the optimal timing of initial screening and 
subsequent testing requires further investigation.  
13.  The low frequency of screening for metabolic syndrome 
in patients with severe mental illness in Durban
S Saloojee,1 JK Burns,1 AA Motala2
1Departments of Psychiatry and 2Diabetes and Endocrinology; Nelson R 
Mandela School of Medicine, University of KwaZulu-Natal
Objective: The objective of this study was to document the frequency 
of testing for all the components of MS in patients with severe mental 
illness in Durban.
Method: This was a cross-sectional study, undertaken from January 
to June 2012, on outpatients with severe mental illness who were 
treated with antipsychotic medication for at least six months. The 
study measured the proportion of participants who were tested for 
MS and their general medical care in the previous year.
Results: The study included 331 (167 male to 164 female) participants, 
with a mean age of 35.2? 11.98 years. The majority (78.8 %) were 
black South Africans. Only 2 subjects (0.6 %) were screened for all 
five components of MS. Regarding the individual components, 
99%, 0.6%, 3.9% and 1.8% were screened for raised BP, abdominal 
obesity, hyperglycaemia, hypertriglyceridaemia and decreased HDL 
cholesterol, respectively. Forty-two per cent relied on the psychiatric 
clinic for their general medical health care.
Conclusion: It is unacceptable that less than one per cent of 
participants were screened for modifiable risk factors. Therefore, 
these results highlight the need to translate guidelines into action. 
14.  Adrenal incidentalomas: spectrum of disease at a 
tertiary hospital in South Africa
L Rademan, K Barnard, B Ascott-Evans, M Conradie
Division of Endocrinology and Metabolism, Tygerberg Academic 
Hospital; and Stellenbosch University
Objective: The aim of this retrospective clinical audit was to assess the 
spectrum of disease in patients who were referred to the Endocrine 
Division with an adrenal incidentaloma.   
Method: Patients referred over a four-year period with an adrenal 
incidentaloma were assessed. Only patients who met the strict 
definition of a true adrenal incidentaloma were included in this study. 
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Results: Twenty-one patients met the inclusion criteria. Demographic 
data were as follows: mean age 53 ? 12 years, 57.1% female; 52.4% 
of patients were of mixed ancestry, 38.1% white; and the mean BMI 
was 31.5 ? 9.3 kg/m2. The mean size of the adrenal incidentalomas on 
radiological imaging was 3.4 ? 2.2 cm. 35.3% of lesions were greater 
than 4 cm, the size regarded as an indication for surgery. Functionality 
was confirmed in four patients: two phaeochromocytomas, one 
subclinical Cushing’s syndrome and one positive screening test for 
hyperaldosteronism. Features that necessiated active intervention 
were present in nine of the 21 patients. Eight patients underwent 
surgery, and histology revealed two phaeochromocytomas, a 
leiomyoma, a multicystic renal cell carcinoma, one metastatic lesion 
and three adrenal cortical adenomas.   
Conclusion: Nonadenomatous pathology was confirmed in 24% of 
this cohort of patients. Despite small patient numbers and lack of 
uniform biochemical evaluation, the spectrum of disease appears to 
be in keeping with that described in the literature. 
15.  Gluteal adipose expression of oestrogen receptor alpha 
associated with ethnic differences in body fat distribution 
in South Africa women
M Tootla, D Keswell, JH Goedecke 
University of Cape Town
We have previously reported on ethnic differences in the relationship 
between the distribution of body fat and IS. The reasons for this are 
not known, but could be explained, in part, by differences in sex 
hormones, which play an important role in determining body fat mass 
and its distribution. Therefore, the aim of this study was to compare 
the expression of oestrogen receptors, ERα and ERβ, and aromatase 
[cytochrome P450 (CYP) 19A)] in gluteal SAT, and examine their 
associations with body fat distribution and insulin sensitivity in black 
and white women. Body composition (DXA), insulin sensitivity 
(frequently sampled intravenous GTT) and ERα, ERβ and aromatase 
mRNA levels were measured in gluteal SAT of 48 normal-weight and 
obese black and white premenopausal South African women. Gluteal 
SAT aromatase mRNA levels did not differ by ethnicity, but were 
positively associated with total body fat in black and white women 
(r = 0.37, p-value < 0.01 and r = 0.41, p-value < 0.01, respectively). 
ERα mRNA levels were higher in black than in white women (1.08-
0.02 vs. 1.02-0.01 AU, p-value < 0.05), and in black women only, 
were negatively associated with centralisation of body fat (r = -0.27, 
p-value 0.02) and insulin resistance (homeostasis model assessment 
of insulin resistance, r =-0.4, p-value <0.01), independent of total 
and central body fat. In conclusion, lower centralisation of body fat in 
black compared to white South African women may be associated 
with their higher gluteal SAT expression of ERα, which may also protect 
against insulin resistance.
16.  The effects of thiazolidinediones on the osteogenic 
differentiation potential of primary adipose-derived 
mesenchymal stem cells
I Cockburn, M van de Vyver, E Andrag and WF Ferris
Division of Endocrinology, Department of Medicine, Faculty of Health 
Sciences, Stellenbosch University
Obesity is associated with serious co-morbidities, including insulin 
resistance which can lead to overt type 2 diabetes mellitus. 
Thiazolidinediones are potent insulin sensitising agents prescribed 
to patients suffering from type 2 diabetes mellitus, and work 
predominantly through the activation of the PPARγ, a master 
regulator of adipogenesis. However, treatment is associated with 
serious side-effects, including secondary osteoporosis, which limit 
therapeutic benefit. This may be owing to the skewing of stem cell 
differentiation away from an osteogenic, and towards an adipogenic 
phenotype. 
This study aimed to directly compare the influence of three 
thiazolidinediones with either a high or low affinity for PPARγ on 
the osteogenic commitment of primary mesenchymal stromal 
cells (MSCs). MSCs were cultured from subcutaneous and peri-
renal visceral adipose depots isolated from male Wistar rats. 
Cells were characterised using flow cytometry and the effects of 
thiazolidinediones on osteogenesis (mineralisation). Any aberrant 
lipid accumulation was quantified.
Cells incubated in an osteogenic stimulating medium, supplemented 
with thiazolidinediones, did not present with a decrease in 
mineralisation, but instead concurrent mineralisation and lipid droplet 
formation was observed. Rosiglitazone and pioglitazone (high PPARγ 
affinity) induced more lipid accumulation than netoglitazone, a dual 
PPARγ/α agonist.
In contrast to current thinking, in this model, which makes use of 
primary stem cells with an uncorrupted cell cycle, thiazolidinediones 
did not promote adipogenesis at the expense of osteogenesis. 
Instead, both processes continued in parallel. In order to develop an 
efficacious treatment for type 2 diabetes mellitus, the mechanisms by 
which thiazolidinediones negatively affect bone need to be studied 
further.
17.  Determinants of obesity and metabolic programming. 
Why is it so difficult to lose weight?
J Dixon
SUNDAY, 13 APRIL 2014
18.  Pathology and molecular biology update of endocrine 
hypertension: what clinicians should know in 2014
H Sasano
Department of Pathology, Tohoku University School of Medicine, Sendai, 
Japan
The great majority of endocrine hypertension is caused by the 
adrenal diseases, particularly pheochromocytoma (intraadrenal 
paraganglioma) and primary aldosteronism. Marked advances in 
molecular pathology have been reported in these disorders. Recent 
studies on pheochromocytoma demonstrated there are more cases 
of hereditary or genetic, malignant and extra-adrenal cases than 
previously considered. In particular, the abnormalities of SDHX genes 
have been demonstrated to be far more prevalent than those of 
RET and VHL. These abnormalities could be screened by succinate 
dehydrogenase subunit B (SDHB) immunohistochemistry. However, it is 
still impossible to discern malignancy of resected pheochromocytoma 
using any molecular pathology diagnostic means at this juncture. 
Primary aldosteronism is currently not considered to be a rare disease. 
It represents 5-10% of patients with hypertension in general. With the 
advent of intravenous adrenal sampling, more cases of CT negative 
adenomas have been detected.  Recently developed CYP11B1/2 
and 3βHSD 1/2 immunostaining has made it possible to determine the 
precise sites of intraadrenal biosynthesis and more daughter, satellite 
tumours and nodules have been demonstrated to be involved in 
aldostrone biosynthesis in these adenomas. Somatic mutations of 
KCNJ5 or ATP1A1 or ATP2B3 result in increased aldostrone biosynthesis 
frequently discovered in many primary aldosteronism adenomas, 
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possibly through calcium-channel regulations and increased 
CYP11B2. It has become important for clinical endocrinologists to 
have these advances above to manage the endocrine hypertension 
patients.
19. Comparison of human leukocyte antigen genotype 
and 21-hydroxylase autoantibody positivity in Addison’s 
disease in South Africa and the USA
I Ross,1 S Babu,2 L Yu,2 T Armstrong,2 L Zhang,2 D Schatz,3 A Pugliese,4 G 
Eisenbarth,2 (posthumous authorship), P Baker2
1University of Cape Town, Cape Town
2Barbara Davis Center for Childhood Diabetes, University of Colorado, 
Aurora, USA
3Diabetes Center, University of Florida College of Medicine, Gainesville, 
USA
4Diabetes Research Institute, University of Miami, Miami, USA
Background: Few data examine (HLA) associations in Addison’s 
disease in South Africa. It is likely that are similarities with patients from 
the USA. We hypothesised that differences may reflect heterogeneity 
in ethnicity and environment, and that similarities might indicate a 
similar aetiology.
Method: South African patients were enrolled as part of a nationwide 
study of Addison’s disease, and matched for healthy control subjects’ 
gender and ethnicity (n = 73). Patients had clinical signs of Addison’s 
disease, positive 21-hydroxylase autoantibodies (21OH-AA), (n = 83) 
in the USA. pHLA alleles were determined using DNA-based typing 
for DQA1, DQB1, and DRB1 class II antigens, as well as HLA-B class 
I antigens. Serum autoantibodies were tested at the Barbara Davis 
Center for both cohorts.
Results: In all SA Addison’s disease HLA-DR3, DR4, the combination 
DR3/DR4 predominated versus controls (p-value ≤ 0.01). This was 
more pronounced in 21OH-AA+ SA-AD. The greatest similarities in 
were in patients with 21OH-AA. The known high-risk USA genotype 
of DR3+/DR4+ (p-value 0.05) and HLA-B8 (p-value 0.02) occurred less 
frequently in the South African group. DQB1*0202 was associated 
with protection from Addison’s disease in 21OH-AA positive patients 
only, despite allelic similarities with high-risk DQB1*0201. HLA-B8 did 
not have an independent effect, apart from the DR3 haplotype. 
HLA-B7 was also higher in the South African 21 OH-AA+ versus 21OH-
AA negative and control populations.
Conclusion: SA-Addison’s disease and US-Addison’s disease 
21OH-AA+ patients have similar HLA risk, indicating similar genetic 
aetiology. HLA class II haplotypes distinguish Addison’s disease risk 
versus controls. Distinct differences in HLA risk between autoantibody-
positive patients, negative patients, and controls, implicate the need 
to test both 21OH-AA and HLA genotypes in clinical risk assessment. 
Differences in class II haplotypes are also potential contributors to the 
development and/or persistence of 210H-AA.
20. Greater hepatic steatosis and lower hepatic  
insulin sensitivity in white compared to black  
South African women
H Victor, JH Goedecke, C Weinreich, J Fan, J Hauksson, K Utzschneider, 
NS Levitt, EV Lambert, SE Kahn, T Olsson
University of Cape Town
Hepatic steatosis is an important factor that links obesity to insulin 
sensitivity. However, to our knowledge, this relationship has not been 
examined in South African women in whom insulin sensitivity differs 
by ethnicity. Therefore, we examined ethnic differences in hepatic 
steatosis in relation to hepatic and peripheral insulin sensitivity in 
obese white and black South African women. Body composition 
(DXA), hepatic steatosis (proton magnetic resonance spectroscopy) 
and insulin sensitivity (two-step isotope labelled, hyperinsulinaemic 
euglycaemic clamp with 10 mU/m2/minute and 40 mU/m2/minute 
insulin infusions) were measured in 16 obese white and 16 obese black 
premenopausal South African women. White and black women were 
matched for age (37.4 vs. 36.5 years, p-value 0.670), BMI (35.2-3.6 vs. 
37.8-4.9 kg/m2, p-value 0.097) and WC (97.3?7.3 vs. 101.6?10, p-value 
0.170). White women had more liver fat than black women (7.8?9.4 
vs. 2.1?1.8%, p-value 0.0.37). Neither whole body insulin sensitivity (M/I: 
6.7?3.8 vs. 6.8?3.2 mg/minute/kg lean body mass/mU/l, p-value 0.872), 
nor rate of disposal of glucose during the high-dose clamp [247 (183-
326) vs. 240 (195-312) mg/minute, p-value 0.880] differed between 
white and black women. However, the rate of disposal of glucose 
during the low-dose clamp was lower in white compared to black 
women [141 (124-188) vs. 188 (107-229) mg/minute, p-value 0.029)]. 
Furthermore, white women had greater hepatic glucose production 
(HGP [mean (interquartile range): 103 (60-115) vs. 45 (0-82) mg/
minute, p-value 0.006], and lower suppression of HGP [18 (8-52) vs. 62 
(34-100)%, p-value 0.008)] than black women. In conclusion, when 
compared to age- and BMI-matched black women, white women 
had lower hepatic insulin sensitivity, which corresponded to their 
higher liver fat content. These findings suggest that the pathogenesis 
of insulin resistance may differ by ethnicity. 
21.  Diabetes in pregnancy
DR Coustan
Obstetrics and Gynecology, Warren Alpert Medical School of Brown 
University, Providence, USA
One hundred years ago, half of diabetic gravidas died during 
pregnancy, as did half of the offspring of surviving mothers. 
Subsequent advances have lowered these risks remarkably to a level 
that is not much higher than that of the general population. Near-
normalisation of maternal glucose levels was the most important 
advance, but techniques for foetal evaluation and neonatal care 
were also critical.  
While preprandial glucose monitoring is often recommended in 
nonpregnant individuals, one-hour or two-hour post-meal testing best 
predicts foetal outcome. The newer insulin analogues have improved 
our ability to manage glycemic control. Rapid-acting analogues have 
not been shown to cross the placenta, and are commonly used in 
pregnancy. Longer-acting analogues have been less fully evaluated 
for pregnancy, but are probably safe. Oral agents such as glyburide 
and metformin both cross the placenta, although neither has been 
shown to be detrimental to the fotus. Longer-term follow-up studies 
are needed, and these drugs are unlikely to be effective in gravidas 
with pre-existing diabetes because pregnancy provokes marked 
increases in insulin resistance. Pregnancy may hasten worsening of 
diabetic retinopathy, and transiently worsen nephropathy.  
The biggest remaining challenge is to increase the participation 
of women with diabetes in pre-pregnancy counselling and 
management, with the goal of lowering glycaemia to prevent 
congenital malformations, which occurs duinring the first 10 weeks 
of gestation.
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22.  Ethnic-specific associations between insulin sensitivity 
and skeletal muscle gene expression in black and white 
South African women
D Keswell, H Victor, NS Levitt, T Olsson, JH Goedecke 
University of Cape Town
We hypothesise that differences in the skeletal muscle expression 
of genes involved in insulin signaling and glucose transport may 
explain our previous finding that black South African women are 
more insulin resistant than white South African women. Therefore, we 
examined ethnic differences in skeletal muscle gene expression and 
the association with insulin sensitivity in black and white South African 
women. Body composition (DXA), insulin sensitivity (euglycaemic 
hyperinsulinaemic clamp) and the expression of insulin receptor 
substrate 1 (IRS-1), syntaxin 4 (STX4) and vesicle-associated membrane 
protein (VAMP) in skeletal muscle were measured in 16 obese black 
and 16 obese white premenopausal South African women matched 
for age (36.5 vs. 37.4 years, p-value 0.670) and BMI (37.8-4.9 vs. 35.2-
3.6 kg/m2, p-value 0.097). In contrast to our previous findings, there 
were no differences in insulin sensitivity (M/I: 6.7?3.8 vs. 6.8?3.2 mg/
minute/kg lbm/mU/l, p-value 0.872) between the two ethnic groups. 
Furthermore, there were no differences in skeletal muscle gene 
expression (IRS-1: 1.2?0.05 vs. 1.2?0.07, p-value 0.757; STX4:1.1?0.04 vs. 
1.1?0.07, p-value 0.669; VAMP: 1.1?0.04 vs. 1.1?0.07, p-value 0.710) 
between black and white women, respectively. However, in black but 
not white women, there was a positive association between M/I and 
the expression of IRS-1 (r = 0.59, p-value 0.045) and the type 4 glucose 
transporter isoform transport genes; STX4 (r = 0.86, p-value 0.001) and 
VAMP (r = 0.76, p-value 0.004). In conclusion, the association between 
insulin sensitivity and genes involved in skeletal muscle insulin signaling 
and glucose transport differs by ethnicity in South African women. 
These results suggest that the pathogenesis of insulin resistance and 
the risk of type 2 diabetes may differ in these two ethnic groups.
23.  Are current clinical trials addressing important issues in 
diabetes care?
K Barnard,1,2 WC Lakey,2 BC Batch,2 K Chiswell,
3 A Tasneem,3 JB Green2,3
1Stellenbosch University, Stellenbosch
2Duke University, USA
3Duke Clinical Research Institute, USA
Objective: Projections that diabetes prevalence will grow globally 
highlight the need for appropriate clinical trials which assess 
interventions to prevent and treat diabetes and its complications. 
To determine whether or not current clinical trials in diabetes 
adequately address these needs, we conducted a descriptive 
analysis of diabetes-related trials registered with ClinicalTrials.gov 
from 2007-2010.   
Method: From a dataset including 96 346 studies registered in 
ClinicalTrials.gov downloaded on 27 September 2010, a subset of 
2 484 interventional trials was created by selecting trials with disease 
condition terms relevant to diabetes.   
Results: Most diabetes-related trials were designed to enrol ≤ 500 
participants (91%). 3.7% of trials targeted persons aged ≤ 18 years, 
0.6% targeted persons ≥ 65 years, and the majority excluded those 
>75 years. Therapy was the primary purpose in 74.8% of trials, while 
10% were preventive. Interventions included drugs (63.1%) and 
behavioural (11.7%). Primary outcomes that included mortality or 
clinically significant cardiovascular complications were listed in 1.4% 
of trials. The distribution of trials according to global region and the 
USA state did not correlate with the prevalence of diabetes.   
Conclusion: Most diabetes-related trials include a relatively small 
number of participants, exclude those at the extremes of age, involve 
mainly drug therapy, rather than preventive or non-drug interventions, 
and do not focus on significant cardiovascular outcomes. Recently 
registered diabetes trials may not sufficiently address important 
diabetes care issues or involve affected populations.
24.  Can point-of-care testing for plasma ketones replace 
the manual enzymatic method in hyperglycaemic 
patients with suspected diabetic ketoacidosis?
A Coetzee, M Hoffman, BAE Ascott-Evans
University of Stellenbosch, Endocrinology
Background: Urine dipsticks for ketones are a widely used screening 
test when diabetic ketoacidosis (DKA) is suspected in patients with 
hyperglycaemia. If urinary ketones are positive, patients are referred 
for further management, often inappropriately, as it is a poor 
surrogate for plasma ketones. Plasma β-Hydroxybutyrate (β-OHB) 
levels > 3mmol/l are diagnostic of DKA, while levels below 1 mmol/l 
are insignificant.
Objectives: To evaluate a hand-held electrochemical [point-of-
care testing (POCT)] ketone monitor and compare it with the gold 
standard manual enzymatic method (MEM) for the detection of 
plasma ketones.
Method:  In a prospective and comparative study, we evaluated 
the measurement of β-OHB by means of POCT and MEM in 61 
consecutive samples from patients at Tygerberg and Karl Bremer 
Hospitals with suspected DKA. Capillary (for POCT) and plasma 
samples (for MEM) were obtained simultaneously and compared for 
accuracy.  Precision was assessed with control samples.
Results: The POCT method was precise [coefficient of variation (CV) 
< 4.5%] and there was a good correlation between the two methods 
with r = 0.95. Regression analysis showed a proportional bias with POCT 
reading higher than MEM. However, when assessed at the relevant 
medical decision limits (β-OHB > 3 mmol/l and < 1 mmol/l), the total 
allowable error (bias plus imprecision) was not exceeded. Therefore, 
patients will still be classified correctly. The POCT had a sensitivity of 
100% and specificity of 89% for DKA (β-OHB >3 mmol/l), while sensitivity 
was 100% and specificity 87.5%.at levels below 1 mmol/l.
Conclusion: The POCT device provided an accurate and precise 
result, and can be used as an alternative to MEM in the diagnosis 
of DKA.
25.  Testosterone, insulin resistance and type 2 diabetes
TH Jones
Centre for Diabetes and Endocrinology, Barnsley Hospital , Barnsley, and 
Department of Human Metabolism, University of Sheffield, Sheffield, UK
There is increased prevalence of hypogonadism in men with type 2 
diabetes. International guidelines now recommend that testosterone 
should be measured in men with diabetes with symptoms suggestive 
of testosterone deficiency. Hypogonadism is a syndrome complex 
which comprises both the symptoms and biochemical evidence 
of testosterone deficiency. Testosterone deficiency is associated 
with reduced insulin sensitivity, hyperglycaemia, visceral adiposity, 
dyslipidaemia, endothelial dysfunction, inflammation and 
hypertension. All of these are key components of MS and type 2 
diabetes. Low testosterone reduces glucose utilisation and increases 
fat deposition.
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Epidemiological studies have found that low testosterone is a 
strong independent risk factor for MS and diabetes.  Androgen 
suppression therapy for prostate carcinoma increases incident 
diabetes and worsens glycaemic control. Recent population- and 
disease-specific (including diabetes) studies have found that low 
testosterone at baseline is associated with an increase in all-cause 
and cardiovascular mortality.
Testosterone replacement therapy (TRT) in hypogonadal diabetic 
men in short-term trials reduces insulin resistance and percentage of 
body fat, and has beneficial effects on glycaemic control, WC, leptin, 
cholesterol, inflammatory markers, and sexual health. Androgen 
receptor sensitivity may affect the response to TRT. More recently, we 
have reported evidence that showed that TRT in hypogonadal men 
with type 2 diabetes improves survival.
Recent data support the role of testosterone in diabetic men, 




CP1. Dysglycaemia and lifestyle factors in Calabar South, 
East Nigeria
O Enang, O Essien, A Otu, O Fasanmade, A Ohwovoriole
University of Calabar Teaching Hospital, Nigeria
Objective: To determine the relationship between dysglycaemia and 
lifestyle factors in residents of Calabar South, East Nigeria.
Method: A cross-sectional survey, comprising 1 134 subjects (645 
males and 489 females), and representative of the entire population 
of Calabar metropolis aged 15-79 was studied. A multistage sampling 
method was applied to select the subjects for the study, which 
involved the selection of four wards by randomisation from the 22 
wards of Calabar, and 50 households from each of the four wards, 
who were selected using the table of random numbers, from which 
eligible individuals aged 15-79 years from the 200 households selected 
were recruited. Using a modification of the WHO STEPS instrument, 
the information obtained included anthropometric indices, smoking, 
physical activity and alcohol intake. Anthropometric indices were 
expressed as a mean (SD). The comparison of means between groups 
was performed using independent Student’s t-test. The strength of 
association between the quantitative variables was determined 
using Pearson’s product-moment correlation coefficient. The level of 
significance was taken to be p-value < 0.05. 
 Results: The overall prevalence of dysglycaemia was 23.6% (24.2% 
males and 22.9% females), and undiagnosed diabetes mellitus was 
present in 6.5% (7.9% in males and 4.7% in females). Lifestyle factors 
significantly associated with dysglycaemia in this study were alcohol 
intake, smoking and physical inactivity. Others risk factors were a 
family history of diabetes mellitus and hypertension.
Conclusion: There is significant association between dysglycaemia 
and lifestyle factors.
CP2. Physical activity and hypertension in  
South African adults
LJ Ware,1 K Rennie,2 L Gafane,1 J Collard,2 T Nell,1 AE Schutte1
1North-West University, South Africa
2University of Hertfordshire, UK
Objectives: Estimates suggest that approximately 6-million South 
Africans have hypertension, with half classified as stage 1 (mild). 
Mindful of the cost of lifelong drug therapy, the South African 
Hypertension Society guidelines suggest delaying drug therapy 
through lifestyle modification (increased physical activity and weight 
management) in all but those with the highest risk. This pilot study 
examined the relationship of BP with physical activity and bodyweight 
in black South African adults employed in physical occupations. 
 Method: Service industry employees (n = 52, 27% male, mean age 
of 42 years, SD 9.4) were recruited from their workplaces. Clinic BP 
was measured with an automated Omron® device and a 24-hour 
Mobil-O-Graph® ambulatory blood pressure monitor (ABPM) fitted. 
A waterproof triaxial accelerometer (GENEActiv®) was placed on the 
non-dominant wrist for seven-day physical activity measurement.
Results: A total of 53% (25 of 47) of the participants had ABPM in the 
hypertensive ranges. With either office BP or ABPM measures, > 70% 
of those with hypertension were stage 1. Overweight and obesity 
(BMI > 25kg/m2) prevalence was 74%. We found that BP correlated 
with WHtR (p-value < 0.05). Physical activity (mean sum of vector 
magnitude, i.e. a summary measure of physical acitivity/day), age 
and WHtR accounted for 25% of the variance in daytime ABPM 
(adjusted R2). 
Conclusion: We found that most hypertension cases are stage 1, and 
that both physical activity and WHtR are independently associated 
with BP. In future lifestyle intervention studies, accurate estimations of 
physical activity and obesity will be important to adequately assess 
the effectiveness of lifestyle modification in South Africa.
CP3. Correlate testosterone levels and the international 
Ageing Males’ Symptoms questionnaire in African  
type 2 diabetic male patients
S Bhana, N Crowther
University of Witwatersrand
Objectives: To describe testosterone status in African type 2 diabetic 
male patients at Chris Hani Baragwanath Academic Hospital and 
to validate the use of an internationally accepted questionnaire 
[Ageing Males’ Symptoms (AMS questionnaire] to identify testosterone 
deficiency.
Method: Male patients with type 2 diabetes attending the diabetes 
clinic at Chris Hani Baragwanath Academic Hospital over a six-
month period were asked to complete an AMS questionnaire. The 
questionnaire was made available in both English and iZulu format. 
Each patient underwent an early morning total testosterone blood 
test. This is a substudy of a PHD titled, To describe the androgen status 
(testosterone and dehydroepiandrostenedione sulphate levels) in 
chronic diseases (diabetes, cardiac disease, autoimmune disease 
and renal failure) and to measure various clinical, psychological, 
biochemical, genetic and biometric markers before and after 
treatment with androgens.
Results: The AMS questionnaire was not adequate in identifying 
the African male patient with type 2 diabetes and testosterone 
deficiency. Testosterone deficiency was found in half of our patients.
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Conclusion: This study’s result concur with previously published 
international data that approximately 50% of type 2 diabetic patients 
have testosterone deficiency. The study identifies the need for a 
screening tool other than the AMS questionnaire.   
CP4. Opportunistic screening as a tool for identification 
of early diabetes mellitus in the sub-Saharan Africa 
population: are we targeting the right people?
KM Leshabari, M Matemu, R Bushiri, R Kalikawe
Walter Hospital, Dar Es Salaam, Tanzania
Objective: To estimate the prevalence of undiagnosed diabetics in 
residents of a typical cosmopolitan area in sub-Saharan Africa by 
using opportunistic screening technique.
Method: A high-risk cohort of residents who included relatives and 
friends of patients living with diabetes mellitus, at-risk staff at the 
municipal hospital, staff of the municipal director’s office, as well 
as relatives of other patients seeking care for CVD at the municipal 
hospitals during National Diabetes Week were invited at random 
to participate in the study. FBG, as well as postprandial glycaemic 
measurements (using capillary blood measurements) were taken 
together with other cardiometabolic risk variables or opportunistic 
screening, and analysed using SAS® statistical software version 9.2. 
An alpha level of 5% was considered to be significant for disproving 
the null hypothesis. Screened positive respondents underwent further 
tests for confirmatory purposes.
Results: The study recruited a total of 189 participants. Three per cent 
of the screened participants were found to have blood glucose 
values in the diabetes range. One in three (32.86%) respondents 
reported that they had a positive family history of diabetes. There was 
a strong and positive correlation between a family history of diabetes 
and a family history of hypertension (γ = 0.6, p-value < 0.0001). 
BMI positively correlated with hypertension screening outcomes 
(γ = 0.266, p-value 0.0017), but not diabetes screening outcomes 
(γ = -0.01, p-value 0.9066).
Conclusion: The positive yield for diabetes screening was relatively 
low in this study population using conversional diagnostic tests. 
Glycaemic measurements in this study population were revealed to 
have a mixture distribution.
CP5. Age at initiation of diabetes-targeted screening  
in sub-Saharan Africa: how applicable are  
American Diabetes Association recommendations  
to African settings?
B Mphumuhila, K Leshabari, R Bushiri
Temeke Municipal Hospital, Dar Es Salaam, Tanzania
Objective: To estimate appropriate age at initiation of diabetes 
opportunistic screening in adults living in a typical cosmopolitan area 
of sub-Saharan Africa.
Method: A cross-sectional analytical targeted screening was 
conducted in a high-risk group in the Ilala Municipality in Dar es 
Salaam. Glycaemic measurements included fasting or two-hour 
postprandial glycaemia. Data were collected using a locally 
prevalidated questionnaire provided by the Tanzania Diabetes 
Association. Analysis was performed using SAS® version 9.2, and 
mainly involved Student’s t-test and Pearson’s product-moment 
correlation coefficient for continuous variables, as well as the chi-
square test for categorical variables. Type 1 error rate was fixed at 5% 
level. Verbal informed consent was sought from participants before 
screening.   
Results: One hundred and eighty-nine volunteers were randomly 
invited to participate in a targeted screening exercise. There was 
a slight female preponderance (50.5% vs. 49.5%). Trend test of 
association between age categories and screening outcomes for 
diabetes revealed a highly significant association (χ2 = 8.5269, df 
= 1. p-value 0.0041). There were more people with pre-diabetes 
in the age group 30-45 years than in the age groups < 30 years or 
> 45 years (χ2 = 35.63, df = 4, p-value < 0.01). Weak but significant 
association was present between age and BP (γ = 0.12, p-value 
< 0.0001), and BMI (γ = 0.23, p-value 0.004). No evidence of correlation 
between age and gender (p-value 0.45) was apparent, but when 
age was categorised according to American Diabetes Association 
recommendations, the association was strong and significant 
(χ2 = 12.02, df = 2, p-value < 0.001).   
Conclusion: Young age had weak correlation with pre-diabetes. 
Older individuals tested positive for diabetes than younger individuals.
CP6. Cardiometabolic risk factors in a high-risk adult 
population in Dar Es Salaam in Tanzania:  
what went wrong?
B Mphumuhila, K Leshabari
Temeke Municipal Hospital, Dar Es Salaam, Tanzania
Objective: To compare the cardiometabolic risks of frank diabetics 
and a high-risk population group in a typical setting in sub-Saharan 
Africa.
Method: Cross-sectional, analytical targeted screening was 
conducted in a pre-defined high-risk group in Temeke Municipality in 
Dar es Salaam, Tanzania. Considered glycaemic measurements were 
either FBG or two-hour postprandial glucose measurements. Data 
were collected using a locally pre-validated questionnaire provided 
by the Tanzania Diabetes Association. Analysis was performed using 
SAS® version 9.2 and mainly involved Student’s t-test and Pearson’s 
correlation for continuous variables, as well as the chi-square test 
statistics for categorical variables. Type 1 error rate was fixed at 5% 
level. Verbal informed consent was sought from participants before 
screening.
Results: Compared to frank diabetics group (n = 35), those with 
negative screening results in respect of diabetes were likely to be 
younger than 30 years (p-value 0.02) and of male gender (p-value 
0.05). Evidence of the difference between the two groups with 
respect to BMI (p-value 0.37), SBP (p-value 0.07) or DBP (p-value 
0.08), as well as alcohol history (p-value 0.046), was barely significant 
or non-significant. Pearson’s correlation between age and SBP, as 
well as DBP, was significant in the diabetic group (Y = 0.404, p-value 
< 0.01), but not for the high-risk group who were screened negative 
(0.30907, p-value 0.0801).
Conclusion: There appears to be a difference between high-risk 
groups who were negative in respect of screening for frank diabetics 
in this study population.
CP7. A retrospective study of myocardial perfusion imaging 
at Inkosi Albert Luthuli Central Hospital, Durban, over a 
12-month period
A Shmendi,1 F Pirie,2 D Naidoo,3 B Tlou,4 W Pilloy,5 AA Motala2
Departments of 1Medicine, 2Diabetes and Endocrinology, 3Cardiology, 
4Biostatistics and 5Nuclear Medicine; University of KwaZulu-Natal
Objective: The relationship between myocardial perfusion imaging 
(MPI) abnormalities, diabetes mellitus and glucose control in South 
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African populations is unknown. It was hypothesised that in subjects 
undergoing MPI for suspected coronary artery disease (CAD), 
those with diabetes would have more extensive perfusion defects, 
and that diabetes control would influence MPI abnormalities. The 
objective was to examine the relationship between the severity of 
CAD diagnosed with MPI in subjects with and without diabetes, and 
to determine the relationship between diabetes control and the 
extent of CAD.
Method: The study was a retrospective chart review of 340 subjects in 
whom MPI scans were performed over a 12-month period. 
Results: Subjects with diabetes had a higher prevalence of abnormal 
MPI, with more extensive ischaemia, compared to subjects without 
diabetes [85.6 vs. 68%, relative risk (RR) 1.26, p-value < 0.01]. Glycated 
HbA1c ≥ 7% was associated with a higher risk of abnormal MPI, with 
more extensive ischaemia, compared to that in those with diabetes 
and HbA1c < 7% (RR 1.13, p-value 0.04), and that in subjects without 
diabetes (RR 1.33, p-value < 0.01).
Conclusion: Subjects with diabetes have more extensive myocardial 
ischaemia compared to subjects without diabetes. Furthermore, 
poorer diabetes control is associated with more abnormalities on MPI 
scanning.
CP8. The impact of gender differences on the risk of 
diabetes mellitus in high-risk group in a typical  
sub-Saharan African environment
K Leshabari, R Bushiri, B Mphumuhila, R Kalikawe
Walter Hospital, Dar Es Salaam, Tanzania
Objective: To assess the impact of gender differences on the risk of 
diabetes mellitus in an adult community in sub-Saharan Africa.
Method: Cross-sectional, analytical targeted screening was carried 
out in a high-risk group in the Ilala Municipality in Dar es Salaam, 
Tanzania. Glycaemic measurements included fasting and/or two-
hour postprandial glycaemia. Several independent risk factors were 
compared with respect to gender. Analysis was carried out using 
SAS® version 9.2, and mainly involved Student’s t-test for continuous 
variables, as well as chi-square test statistics for categorical variables. 
An alpha level of 5% was used to disprove the null hypothesis. Verbal 
informed consent was obtained from participants before screening.
Results: The study recruited a random high-risk sample of 189 
participants. Females constituted 50.5% of the sample. During 
screening, 20.2% and 23.2% of participants screened positive for 
diabetes mellitus and hypertension, respectively. A positive diabetes 
family history was reported in 13.7% of the sample. Females recorded 
higher glycaemic levels than men (p-value 0.0399). No evidence was 
found of a statistical significant differences between gender and age 
(p-value 0.45), BMI (p-value 0.33), and SBP (p-value 0.37). Diabetes 
status showed a significant association with age (χ2 = 12.2735, df = 4, 
p-value 0.015). The correlation between diabetes family history and 
diabetes screening outcome were barely significant (γ = 0.45, p-value 
0.058).
Conclusion: There was fairly high yield of positive screening outcome 
for both diabetes and hypertension in the sample. Females had higher 
careened glycaemic levels than males. Positive diabetes outcome 
was found in older than younger participants. Most participants 
revealed no previous history of diabetes screening.
CP9. Diabetes mellitus research: Tanga City, Tanzania
E Kitiku, S Moizali
Background: Tanga City has eight districts. Diabetes management 
and care are carried out in only two centres, Bombo and Teule District 
Hospitals. An important aspect of management and care is providing 
health education on nutrition, lifestyle modification and exercises; 
and conducting basic investigations into the self-management 
of diabetic patients in order to prevent diabetes complications. 
According to statistics at Bombo Hospital, there were 1 580 patients 
between January 2004 and March 2012. There were more females 
than males. The monthly record of attendance included patients 
on injection insulin, type 1 patients, children younger than 18 years, 
patients on oral hypoglycemic drugs, patients on special diets and 
who exercise, and those with diabetic complications.
Method: Activities performed in the diabetes clinic include providing 
health education on diabetes and its general predisposing factors, 
as well as on diet, lifestyle changes, and the importance of exercise, 
self-management, investigations and screening for diabetes 
complications, treatment, BMI calculations, the taking of vital signs, 
completing follow-up forms and general management and care, 
which are all performed at the Bombo Region Referral Hospital.
Results: Bombo Hospital had 1 580 patients between 2004 and 
2012. Other findings were that male diabetes patients were more 
underweight than females and that females diabetes patients were 
more obese than males, and very obese patients were female. More 
than 75% of the diabetes patients were hypertensive. Education on a 
healthy diet and dietary modification and the importance of exercise 
is needed. More than 50% of diabetes patients has uncontrolled 
blood glucose. More than 85% type 1 and type 2 diabetes mellitus 
patients on injection insulin were underweight. Poverty and cultural 
beliefs contribute to this.
Conclusion: According to data obtained through self-administered 
oral questions, interviews and observations, 95% of diabetes patients 
didn’t know the importance of modified management and care 
with respect to diet, and self-management with regard to injections, 
storage, injection technique and sites, or even what to do in the 
event of hypoglycemia. Only 5% of health personnel had an idea of 
how to advise diabetes patients to modify their diet or lifestyle. Most 
of them did not have an idea of what to suggest. Obstacles hindering 
diabetes services include poor health personnel participation in 
diabetes services, a shortage of staff, the fact that the community 
does not have information on diabetes, predisposing factors, signs, 
symptoms and the prevention thereof. Diabetes services are not 
available in dispensaries and district hospitals. Staff are not motivated 
or incentivised. It is recommended that workers and communities 
should be trained with respect to diabetes services so that all can test 
for diabetes mellitus and be familiar with it.
CP10. Lipoma of the clitoris presenting as a disorder of  
sex development: a case report
S. Mda, FPR de Villiers
Department of Paediatrics and Child Health, Medunsa Campus, 
University of Limpopo
Introduction: The term, disorders of sex development (DSD), is used to 
describe conditions in which development of chromosomal, gonadal, 
or anatomical sex is atypical. A working diagnosis of DSD should be 
followed using timely investigations to enable management decisions 
to be taken without undue delay. 
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Case report: A three-day-old infant presented to the neonatal 
ward at Dr George Mukhari Hospital and was assessed as having 
an enlarged clitoris. The mother was 28 years of age, and had not 
used any medications during pregnancy and had no evidence of 
virilisation. An examination of the infant revealed no abnormalities 
other than an enlarged clitoris of 1.8 cm, with no palpable gonads, 
and a normal anal orifice. The birthweight was 3.3 kg, and the length 
and head circumference were normal for gestational age. The infant 
was not dehydrated, with normal BP. A pelvic ultrasound confirmed 
the presence of a uterus. A working diagnosis of DSD was made 
owing to congenital adrenal hyperplasia. 17-α-hydroxyprogesterone 
levels at age five days were 16 nmol/l, with testosterone levels of 
0.1 nmol/l. Repeat 17-α-hydroxyprogesterone levels at one month 
of age were 2.5 nmol/l. Chromosomes results were 46 XX. The infant 
was referred to the urologist, who performed a clitoral reduction. A 
biopsy of the clitoral body revealed a lipoma. The external genitalia 
appearance was satisfactory one month postoperatively.
Conclusion: Lipomas of the vulva are rare and typically occur in 
adults. The clitoromegaly that was observed raised suspicions of DSD, 
which turned out to be incorrect. 
CP11. Pseudohypoparathyroidism type IA:  
the Chris Hani Baragwanath Hospital series
V Nicolaou, R Shires
Chris Hani Baragwamnath Academic Hospital; and University of the 
Witwatersrand
Objective: Pseudohypoparathyroidism (PHP) is a rare disorder (1:100 
000), first described in 1942 by Albright et al. It is characterised by 
hypocalcaemia and hyperphosphataemia due to resistance to 
the parathyroid hormone (PTH). Various types of PHP have been 
described. It may be due to an abnormality involving the α-subunit of 
the stimulatory G-protein, i.e. type I, or a defect involving adenylate 
cyclase, i.e. type II. Type IA is the most common, and is associated with 
a typical phenotype, known as Albright’s hereditary osteodystrophy 
(AHO). The objective was to report the first cohort of PHP-IA patients 
in the South African population. 
Method: Eight black patients, five females and three males, aged 
six months to 28 years at the time of initial presentation, attending 
the Endocrine Clinic at Chris Hani Baragwanath Academic Hospital, 
were studied.
Their presenting symptoms, family history, phenotypic characteristics, 
biochemical and hormonal profiles and radiological findings were 
documented. 
Results: Patients were initially hypocalcaemic, with elevated PTH 
levels. Regarding other markers of hormone resistance, TSH levels 
were raised in five of the patients in the presence of normal thyroid 
hormone levels (62.5%), and luteinising hormone (LH) levels were 
elevated in three patients (37.5%).  All of the patients had one or more 
features of AHO, but only three (37.5%) had brachymetacarpalia. 
Intracranial calcifications were documented in six patients (75%) by 
CT scanning.
Conclusion: This is the first documented cohort of patients with PHP 
in South Africa.
CP12. A rare case of Cushing’s syndrome
S Akerman, E Delport
Steve Biko Academic Hospital
A 42-year-old male patient was referred by a specialist physician 
with features of Cushing’s syndrome, as well as recently diagnosed 
hypertension and type 2 diabetes mellitus. Clinical features 
included moon facies, a dorsicervical hump, telangiectasia, 
proximal myopathy, centripetal obesity and purple striae. Special 
investigations revealed an elevated 24-hour urinary-free cortisol 
with elevated midnight salivary cortisol, and failure to suppress using 
the low-dose dexamethasone suppression test. ACTH values were 
also elevated. Magnetic resonance imaging showed a normal 
pituitary gland with only a right-sided antrochoanal polyp of 1.5 x 1 
cm, that extended into the middle ethmoidal cells. Contrasted CTs 
of the chest and abdomen to evaluate for an ectopic ACTH focus 
were performed and found to be normal. A technetium-99m  
scan was then performed which demonstrated a mass in the right 
paranasal area with somatostatin receptors. Surgical removal and a 
histopathological examination confirmed it to be an ACTH-secreting 
adenoma. 
CP13. Are African children with diabetes adequately 
supported by their families?
FPR de Villiers
The Department of Paediatrics and Child Health, MEDUNSA Campus of 
the University of Limpopo, Pretoria
Objectives: Coping with diabetes control is difficult for newly 
diagnosed and experienced patients; the former because of the 
complex technical requirements that they suddenly have to face, 
and the latter because of constant repetition in respect of tests, 
insulin administration and dietary vigilance. Some of our patients 
have stored insulin inappropriately or measured it incorrectly. Children 
need to be able to give their own insulin or conduct home blood 
glucose monitoring without help before they can be expected to 
cope with such complex tasks. The objective was to establish whether 
or not patients are adequately supported by their family in terms of 
giving injections and conducting monitoring.
Method:  Patients attending the paediatric and young adult diabetic 
clinics were interviewed. Permission was granted by the ethics 
committee and informed consent obtained.
Results: Forty subjects were interviewed. Ages varied from 7-31 years. 
Twenty-five were younger than 18 years of age. The duration of 
diabetes varied from three months to 10 years in paediatric patients. 
Of 25 patients, 17 measured the insulin themselves, while five mothers 
did so. Twenty children then administered the injection. The dosages 
were checked in seven cases. The mothers of four children younger 
than 10 years measured their insulin, but the children injected it 
themselves. Eight of the nine children aged 1-15 years measured 
and injected their insulin themselves. However, the dosages were 
checked by an adult in only two cases.
Conclusion: It is appropriate that older children take responsibility for 
measuring and injecting their insulin. However, younger children do 
not seem to be sufficiently supported by their families.
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CP14. A case of primary pigmented nodular  
adrenocortical disease
NG Mahyoodeen, Z Laher, MV Omar, JA George, C Leisegang, K 
Parbhoo, R Shires
Chris Hani Baragwanath Academic Hospital
Primary pigmented nodular adrenocortical disease (PPNAD) is a 
rare cause of Cushing’s syndrome.  The various forms of nodular 
adrenocortical disease account for 10% of cases of ACTH-
independent Cushing’s syndrome, and PPNAD comprises a small 
fraction thereof.
A 14-year-old male was referred to the endocrine clinic at Chris 
Hani Baragwanath Hospital by the paediatric department with 
clinical features of Cushing’s syndrome. His older brother had a 
history of having been managed surgically for Cushing’s syndrome. 
Biochemistry confirmed the diagnosis of Cushing’s syndrome, as 
evidenced by an elevated midnight cortisol of 566 nmol/l (138- 
220 nmol/l), an elevated urine-free cortisol of 1 052 nmol/24 hours 
(57.7-806.8 nmol/24 hours), as well as failure of suppression on the 
1 mg overnight dexamethasone suppression test.
Furthermore, a paradoxical increase in his urinary cortisol excretion 
followed the low-dose dexamethasone suppression test, rising from 
680 nmol/24 hours to 1649 nmol/24 hours, characteristic of PPNAD. 
Adrenal aetiology was supported by an undetectable ACTH level.
CT imaging of the adrenal glands showed no evidence of either an 
adenoma or bilateral adrenal hyperplasia. However, adrenal vein 
sampling revealed bilateral marked elevations of cortisol bilaterally, 
as compared to peripheral cortisol levels (right adrenal vein 
4 265 nmol/l, left adrenal vein 1 1185 nmol/l, and peripheral 
455 nmol/l).
The patient underwent bilateral laparoscopic adrenalectomy. 
Histology confirmed a diagnosis of primary pigmented nodular 
adrenal hyperplasia. The patient displayed no clinical features of 
Carney complex. Genetic testing was not undertaken.
PPNAD is a rare cause of ACTH-independent Cushing’s syndrome, 
but remains an important consideration, especially since radiological 
features may be misleading.
CP15. Disseminated large cell neuroendocrine  
carcinoma associated with ectopic 
adrenocorticotropic hormone secretion
A van der Walt, K Huddle, S Pather, A Korb
University of Witwatersrand, Chris Hani Baragwanath Academic Hospital
EAS secretion is associated with a heterogenous spectrum of NETs, as 
well as non-NET tumours. Both EAS and NET are relatively uncommon. 
LCNEC is considered to be a poorly differentiated NET and is very 
rarely associated with EAS. Only case reports of EAS associated with 
LCNEC have been documented. We present a case of disseminated 
LCNEC associated with EAS. The LCNEC was diagnosed on bone 
marrow trephine biopsy, and the likely but unproven primary was a 
NET arising from the superior mediastinum, which also caused superior 
vena cava syndrome at presentation. 
CP16. Diabetes care via telemedicine in South Africa
D Segal,1 G Rowe,2 R Johnson,2 U Shannon,2 S Plaatjie,2 A Schwulst2
1CDE, Parktown
2Guidepost, Rosebank
Objective: Type 2 diabetes mellitus is a national epidemic. Excellent 
treatment algorithms and medications exist, yet the ability to achieve 
SEMDSA-specified glycaemic targets remains poor for a number of 
reasons, including heavy reliance on self-care, inappropriate systems, 
patient and doctor barriers to insulin initiation, and intensification and 
the requirement for data-driven therapy modification. 
Method: Four hundred and eighty insulinised type 2 diabetes mellitus 
patients volunteered to participate. After an initial structured face-
to-face education session with a Doctor of Nursing Education (DNE), 
ongoing data-driven instruction on dose titration to reach SEMDSA-
defined glycaemic targets and coaching on meal planning, exercise 
and insulin use were carried out via DNEs in a call centre operating 
on the Guidepost® software platform. Patients submitted structured 
self-monitoring of  glucose readings to the platform via SMS. The 
frequency of structured testing and clinical interactions varied per 
patient.
Results: The overall uptake and acceptability of the programme 
was high, with over 26 000 glucose readings submitted. Patient and 
doctor feedback was positive, with 88% retention over 18 weeks. 
Target range pre-meal blood glucose values between 4 and 7 mmol/l 
increased 62% from baseline to week 18, and the time spent in the 
hyperglycaemic (blood glucose > 11 mmol/l) and hypoglycaemic 
(≤ 3.9 mmol/l) ranges declined by 46% and 25%, respectively.
Conclusion: A patient-centered diabetes care and education 
telemedicine programme in insulin-treated subjects with type 2 
diabetes mellitus, that utilises a combination of structured testing, 
SMS-based data input, periodic data-driven telephonic coaching 
and validated learning has a good uptake, is acceptable to patients 
and healthcare providers, and results in improved glycaemia.
CP17. To determine the precalence of lipodystriphy and 
metabolic changes in human immunodeficiency  
virus-infected patients on highly active antiretroviral 
therapy at Ilala HIV clinics between 2009 and 2010
D Narciss
Dar Es Salaam
Objective: MS refers to a clustering of cardiovascular risk factors that 
include diabetes, obesity, ageing, physical inactivity, dyslipidaemia, 
hypertension and lipodystrophy. Lipodystrophy is more common in 
people living with acquired immune deficiency syndrome (AIDS) using 
highly active antiretroviral therapy (HAART), and  there is little data on 
MS in people living with AIDS using HAART in our environment.  This 
study was carried out to determine the prevalence of lipodystrophy 
and metabolic changes in HIV-infected patients on HAART at Ilala 
HIV clinics between 2009 and 2010. 
Method: A retrospective study was performed and analysed using 
SPSS® programme version 15, whereby 652 people older than 
18 years living with HIV/AIDS, who had been tested for lipids profile 
and using HAART for not less than nine months, were recruited from 
five care and treatment centres out of 13 centres in Ilala District in 
Dar es Salaam, Tanzania. This study was performed for one year from 
January 2011 to December 2011. 
Results: Of 652 people living with HIV/AIDS, 332 (50.9%) were females 
and 320 (49.1) males. Approximately 60% of the participants were 
obese, and three quarters (75) of the obese participants were aged 
35-54 years (p-value < 0.01). Of the 156 participants with elevated 
BP, only 37 (23.7%) were on antihypertensive drugs, and there were 
serum triglycerides in two thirds of participants with elevated BP aged 
35-54 years (p-value < 0.01).The magnitude of MS in the protease 
inhibitor (PI)-based regimen was significantly higher than that in the 
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non-nucleoside reverse-transcriptase inhibitors (NNRTI)-
based regimens, in those participants who had been using HAART for 
more than 18 months (p-value < 0.01).
Conclusion: This study observed that there was high prevalence 
of MS by 42% in people living with AIDS using HAART, with a strong 
association of person, age group, dyslipidaemia and duration in both 
NNRTI- and PI-based regimens.
CP18. Diabetes self-management education programmes  
in high- and low-mortality developing countries
L Dube, S van den Broucke, M Housiaux, K Rendall-Mkosi
Univesite Catholique de Louvain, University of Pretoria
Objective: Diabetes mellitus is often considered to be a disease of the 
affluent, but is increasingly becoming a burden for the developing 
countries as well. Self-management education is a key factor in the 
care of diabetic patients. However, its implementation in developing 
countries is not well documented. The objective was to identify 
and synthesise published literature on diabetes self-management 
education interventions in high- and low-mortality developing 
countries to determine current practices, identify gaps and assess 
effectiveness. 
Method: PubMed, Medline, PsycInfo, PsycArticles and Google 
Scholar were searched for peer-reviewed articles on type 2 diabetes 
or pre-diabetes published in English between 2009 and 2013. The 
World Bank and WHO burden of disease criteria were applied to 
distinguish between developing countries with high and low mortality. 
Information on intervention characteristics, cultural sensitivity and 
access by people with low literacy was extracted using a validated 
check-list. 
Results: Twenty-three studies described in 25 articles and three reviews 
were identified. Studies from high-mortality countries were mostly 
observational, those from low mortality, mostly experimental. The 
interventions were generally effective on behavioural change and 
glycaemic control by patients on short-term follow-up (≤ 6 months). 
Information about the theoretical basis of diabetes self-management 
education interventions was often missing. Fifty-seven per cent of 
studies reported on the cultural tailoring of interventions. Only 17% 
reported on the training of providers, and only 39% of programmes 
were accessible to people with low literacy. 
Conclusion: Diabetes self-management education programmes 
in developing countries are effective in the short-term, but must be 
tailored to cultural aspects of the target population.
BASIC SCIENCE POSTERS
BS1. Effects of commercially available sugar  
substitutes in an experimentally induced rat  
model of type 2 diabetes
S Dlamini, N Mbambo, S Islam
Department of Biochemistry, University of KwaZulu-Natal 
Diabetic patients increasingly substitute sucrose with non-nutritive 
sweeteners (NNS). Most studies have been conducted using NNS in 
their pure form, although this is not what people consume in general. 
Hence, the present study investigated the effects of commercially 
available NNS in a type 2 diabetes rat model. Six-week-old male 
Sprague-Dawely rats were randomly divided into seven groups: 
normal control, diabetic control, diabetic aspartame diabetic 
sucralose, diabetic cyclamate, diabetic saccharin and diabetic 
stevia. Type 2 diabetes was induced experimentally in all groups, 
except the normal control group. Animals with blood glucose 
levels > 300 mg/dl were considered to be diabetic. During the 
13-week experimental period, the two control groups were given 
normal drinking water, while the other groups received aspartame-, 
sucralose-, sodium cyclamate-, saccharin- and stevia-based NNS 
solutions ad libitum, respectively, at a concentration equivalent to 
the sweetness of a 10% sucrose solution. Significantly increased food 
intake was only observed in the diabetic cyclamate group, while 
increased fluid intake was observed in both diabetic cyclamate and 
diabetic stevia groups. Alkaline phosphatase (ALP) was significantly 
increased in both diabetic sucralose and diabetic saccharin groups, 
while lactose dehydrogenase (LDH) was elevated in the diabetic 
sucralose and diabetic stevia groups. All the treated groups had 
higher but nonsignificantly elevated non-FBG levels than the diabetic 
control group. The results of this study indicate that some of the 
commercially available NNS may cause increased body weight, 
polydipsia, polyphagia, serum ALP and LDH in type 2 diabetes, and 
may worsen the diabetic condition in the long term. 
BS2. Effects of commercially available non-nutritive 
sweeteners on diabetes-related parameters in  
non-diabetic rats
S Islam, N Mbambo, S Dlamini
Department of Biochemistry, University of KwaZulu-Natal
Type 2 diabetes is a global health problem, and continues to 
affect more and more people. In South Africa, the epidemiological 
transition has led to lifestyle changes, such as unhealthy diet and 
reduced physical activity, which has led to an increase in the 
prevalence of type 2 diabetes. Overweight, obese and diabetic 
individuals substitute sucrose with NNS to reduce their total calorie 
intake, and also to avoid the quick spike of blood glucose levels and 
other associated complications. 
The present study aimed to examine the effects of commercially 
available NNS on diabetes-related parameters in non-diabetic rats. 
Six- to seven-week-old male Sprague-Dawley rats were randomly 
divided into seven groups: control, sucrose, aspartame, sucralose, 
stevia, cyclamate and saccharin. The control group received normal 
drinking water, while the sucrose, aspartame, sucralose, stevia, 
cyclamate and saccharin groups received sucrose, aspartame, 
sucralose, stevia, sodium cyclamate and saccharin-based NNS, 
respectively. Each NNS was used at a concentration equivalent to the 
sweetness of 10% sucrose. At the end of the five-week experimental 
period, most of the diabetes-related parameters had worsened in the 
aspartame- and cyclamate-consuming groups, while opposite results 
were obtained for the stevia-fed group, compared to the control 
and sucrose-fed groups. No significant effects were observed in the 
sucralose- and saccharin-fed groups. The data of this study suggest 
that aspartame- and cyclamate-containing sweeteners may not be 
suitable for diabetic patients when stevia can be a better NNS with 
anti-diabetic potential.
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BS3. Functional rescue of inactivating mutations of the 
human G protein-coupled receptors and luteinising 
hormone receptors with cell-permeant small 
molecules: a new pharmacological target
R Millar,1,2 CL Newton2
1Mammal Research Institute, Pretoria
2 MRC Receptor Biology Unit, University of Cape Town
Mutations in G protein-coupled receptors (GPCRs) have been 
identified for almost all endocrine hormone-signalling deficiencies. 
Although some inactivating mutations impair ligand binding 
or coupling to signalling pathways, the majority cause protein 
misfolding, consequent failure of translocation to the cell membrane 
and intracellular degradation. Some cell-permeant ligands 
(pharmacological chaperones) have been shown to “rescue” the 
cell surface expression of misfolded mutant GPCRs by stabilising 
their correct folding within the endoplasmic reticulum. We examined 
the ability of GnRH small-molecule antagonists and allosteric small-
molecule LH agonists to rescue poor expression and restore signalling 
of mutant human GnRH and LH receptors. The majority of mutant 
receptors were retained in the cytoplasm while wild-type receptors 
were localised at the cell membrane. Incubation of cells expressing 
the mutant receptors with cell-permeant small molecules increased 
receptor expression and cell surface localisation. Moreover, 
stimulation of signalling with natural hormones was restored. We also 
showed that the LH allosteric agonist was able to restore signalling 
to mutant receptors that were incapable of binding LH. This is the 
first demonstration of a small-molecule GPCR allosteric agonist that 
functionally rescues both intracellularly retained and ligand-binding-
deficient mutant LH receptors. This is particularly pertinent for the 
treatment of infertile patients bearing LH mutations for whom there 
is no current therapy.
BS4. Exploring the molecular basis and phenotypic 
spectrum of reproductive disorders in South Africa
R Millar, A Katz, I Ross, N Pitteloud, A Dwyer, R Millar, Arieh Katz, Ian Ross 
Universities of Cape Town and Pretoria
N Pitteloud, A Dwyer, C XU
University of Lausanne and the Centre Hospitalier Universitaire,  
Lausanne, Switzerland
Objective: Congenital hypogoandotropic hypogonadism (CHH) is a 
reproductive endocrine disorder caused by absent gonadotropin-
releasing hormone (GnRH) secretion or action. This rare genetic 
disorder (1:10 000) is characterised by absent or incomplete puberty, 
with resulting infertility. This disorder has a strong genetic component 
with 20 disease genes discovered to date, yet no known genetic 
cause is attributed to two thirds of CHH patients. This project aimed to 
elucidate the genetic basis of reproductive disorders in South African 
CHH patients, and explore the biology of identified human mutations 
using cutting-edge approaches. This will be accomplished via a 
partnership between groups with complementary expertise in GnRH 
biology, clinical medicine and human genetics. 
Method: The method involved detailed clinical phenotyping studies, 
next-generation sequencing platforms (exome sequencing), 
bioinformatics, and in vitro characterisation of identified mutations.
Results: The initial bioinfomatic pipeline has been developed 
to specifically filter exome data and identify high-quality novel 
candidate genes that relate to reproduction. Presently, confirmation 
studies are underway to characterise three novel genes. Efforts to 
identify additional clinical South African partners, i.e. endocrinologists, 
pediatricians and geneticists, for collaboration, is ongoing.
Conclusion: We believe that this collaboration will identify novel 
genes that underlie CHH, and will reveal new areas in the biology 
of reproduction via the work of the South African team. Also, this 
network will provide a resource for providers who care for CHH 
patients to address clinical questions and problems relating to this 
rare disorder. Ultimately, we aim to use this scientific insight to identify 
novel biomarkers and to target therapies for infertility that will benefit 
patients and families. 
BS5 The insulin-mimetic agent, vanadate, impedes lipid 
accumulation in adipose-derived stem cells
FA Jacobs, SH van Gijsen, WF Ferris
Stellenbosch University, Stellenbosch
Objective: Vanadate has been described as an insulin-mimetic 
agent because vanadate treatment improves glucose homeostasis 
in diabetic patients. Although vanadate does not bind to the insulin 
receptor, it activates insulin signalling by inhibiting protein tyrosine 
phosphatase 1B (PTP1B), a negative regulator of the insulin receptor 
pathway. Activation of the insulin signalling pathway leads to the 
synthesis and accumulation of lipids in order to store energy and the 
differentiation of preadipocytes into mature adipocytes. Previously 
conflicting results have been reported on the role of PTP1B during 
differentiation of immortalised 3T3-L1 preadipocytes into mature 
adipocytes. In one study, PTP1B knockdown improved adipogenesis, 
while in another, the PTP1B inhibitor, vanadate, prevented 
adipogenesis. These conflicting reports led us to investigate the 
effects of vanadate on adult, primary, adipose-derived stem cells 
(ADSCs), as immortalised cell lines such as 3T3-L1 have disrupted cell 
cycles which may influence differentiation.
Method: ADSCs were isolated from subcutaneous and perirenal 
visceral rat tissue, cultured, differentiated into adipocytes in the 
presence or absence of vanadate, and followed by quantification of 
the lipid content by Oil Red O® staining. 
Results: Vanadate significantly reduced lipid accumulation during 
adipogenic differentiation in subcutaneous and perirenal visceral 
ADSCs by 45% (SD 0.7%, p-value < 0.05) and 46% (SD 3%, p-value 
< 0.05) respectively, in three independent experiments.
Conclusion: Our results demonstrated that the PTP1B inhibitor, 
vanadate, reduced lipid accumulation, in contrast to that in the 
PTP1B knockdown studies. This suggests that although vanadate may 
inhibit PTP1B, the effects of vanadate on lipid accumulation may be 
mediated via the modulation of other pathways. 
